Whitepapers
Innovative Access Agreements: A potential payer solution for Cell & Gene Therapies
A US and EU perspective By Daniele Severi Bruni & Sophie Schmitz What’s the idea? Payer concerns over increasing cost of therapies and uncertainty of
September 21, 2018
